News

Stamford, CT, and Bothell, WA, June 20, 2018 (Booth #414) –

Allendale, N.J., June 12, 2018 (Booth #4) –

Stamford, CT, June 11, 2018 – FUJIFILM Medical Systems, U.S.A., Inc

FUJIFILM Cellular Dynamics, Inc., licenses University of California – Irvine’s technologies for derivation of microglia

June 4, 2018

Fujifilm to also showcase collaboration offerings at BIO International Convention (BIO) 2018 exhibition center June 5 – 7, 2018 at booth #863

Allendale, N.J., May 31, 2018 (Booth #1015) –

Stamford, CT, May 30, 2018 (Booth #507) –

Stamford, CT, May 30, 2018 (Booth #507) –

May 25, 2018

COLLEGE STATION, Texas, May 23, 2018 ‒ FUJIFILM Diosynth Biotechnologies (Fujifilm)

Allendale, N.J., May 15, 2018 (Booth 2915)–

Allendale, N.J., May 15, 2018 (Booth 415) – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of endoscopic imaging solutions, will connect with nearly 2,000 GI professionals at the Society of Gastroenterology Nurses and Associates (SGNA)

STAMFORD, Conn., May 15, 2018 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging  and medical informatics solutions, today announced that it will showcase its comprehensive portfolio of pediatric solu

May 14, 2018

Clinical Development of Liposome Drug for Improvement of Pharmacological Efficacy through Selective Delivery of Anti-Cancer Agent to Tumors

May 9, 2018

Valhalla, N.Y.

TOKYO, Japan– April 11, 2018 – Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced the company will partner with Mylan N.V. (NASDAQ: MYL) to commercialize FKB327, a biosimilar to Humira^® (adalimumab) developed by Fujifilm Kyowa Kirin Biologics.

Clinical Trials to Be Conducted for a Novel Drug Approval　

Fujifilm’s newest innovations in digital radiography delivers image quality, dose efficiency and improves patient safety.

Maximizing synergies and further expanding the bio-medical business

March 29, 2018

TORONTO, March 21, 2018 – FUJIFILM VisualSonics Inc.

Stamford, CT, March 16, 2018 (Booth # 2750)–

3D image analysis system for medical use “SYNAPSE VINCENT”,
hybrid instant camera “instax SQUARE SQ10” and others

March 12, 2018

Toyama Chemical Co., Ltd. (Head Office: Shinjuku-ku, Tokyo; President: Junji Okada), a FUJIFILM Company, has announced that it has started to enroll patients for phase III clinical study in Japan of the antiviral drug favipiravir for ixodid tick-borne infectious disease, serious fever with thrombocytopenia syndrome (SFTS).

The latest workstation will be on display this spring at the National Consortium of Breast Centers (NCoBC) conference and the Society of Breast Imaging (SBI) Symposium.

Stamford, CT, March 1, 2018 (Booth #6637)– FUJIFILM Medical Systems U.S.A., Inc.,

Allendale, N.J., February 27, 2018– As a leading provider of endoscopic imaging devices,

Patients in communities across the United States will reap the benefits of 3D mammography with new installations.

Advanced production system utilizing cutting edge ICT technologies to be adopted,

College Station, TX, U.S.A., January 24, 2018 ‒ FUJIFILM Diosynth Biotechnologies (Fujifilm), a leading Contract Development and Manufacturing Organization (CDMO) with experience focused on the development and manufacture of recombinant biopharmaceuticals and Advanced Therapies, has announced the opening of it

 The Company also revealed expansion of its Apollo™ Cell Line Development capabilities at its Billingham, U.K. Site

MORRISVILLE, N.C.,  Jan.

MADISON, Wis., Dec. 27, 2017— Cellular Dynamics International (CDI), a FUJIFILM company, the leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and differentiated tissue-specific iPSC-cells, announced that its iCell® Cardiomyocytes were launched into space via SpaceX’s 13th commercial resupply services mission to the International Space Station on Dec.15, 2017.

Allendale, N.J., December 11, 2017 (Booth #400) – FUJIFILM Medical Systems U.S.A. Inc.,- Endoscopy, will feature its endoscopic imaging solutions at the 41st Annual New York Course of the New York Society for Gastrointestinal Endoscopy (NYSGE). NYSGE will be held December 14-15 at the New York Marriott Marquis Hotel in Times Square, NY, NY. This year at NYSGE Fujifilm will highlight its latest technology featuring the recently launched ELUXEO®.

Signs joint research agreement to create gene therapy drugs using genome editing technology 

December 19, 2017

FUJIFILM Corporation (President: Kenji Sukeno) signed an agreement on December 19th for the investment of 470 million yen in EdiGene Corporation, a drug discovery startup, participating its series A round.  As a result, Fujifilm will acquire 11.7% of EdiGene’s total shares. Along with this equity investment, the companies have signed a joint research agreement aimed at discovering gene therapy drugs¹.

Allendale, N.J., December 6, 2017– As part of its ongoing commitment to promoting early detection of colon cancer, FUJIFILM Medical Systems U.S.A., Inc. - Endoscopy today announced its partnership with Fight Colorectal Cancer, the leading colorectal cancer advocacy organization. The two organizations will support a national movement called “One Million Strong” that brings together the strength of more than one million colorectal cancer survivors living in the United States.

STAMFORD, Conn., November 26, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of enterprise imaging and medical informatics solutions, today announces the expansion of Fujifilm’s artificial intelligenc

STAMFORD, Conn., November 20, 2017 –  FUJIFILM Medical Systems U.S.A., Inc., a leadin

STAMFORD, Conn., November 20, 2017 – FUJIFILM Medical Systems U.S.A., Inc

Fujifilm debuts the new FDR Go PLUS ^version and announces installations of the FDR AQRO mini mobile digital radiography solution

STAMFORD, Conn., November 21, 2017 –  FUJIFILM Medical Systems U.S.A., Inc., a leadin

Stamford, CT, November 21, 2017 (Booth #4111, South Hall) – FUJIFILM Medical Systems U.S.A., Inc.,

Stamford, CT, November 21, 2017 – FUJIFILM Medical Systems U.S.A., Inc.,

BOTHELL, WA, November 21, 2017 – FUJIFILM SonoSite Inc., spe

Stamford, CT, November 21, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic i

Billingham, United Kingdom, November 21, 2017 – FUJIFILM Diosynth Biotechnologies, a leading global Contract Development and Manufacturing Organization (CDMO), is pleased to announce that its Chief Executive Officer, Steve Bagshaw, has been awarded “North East Business Executive of the Year 2017”; a prestigious award organized by The Journal in Newcastle, U.K.

Acquiring new transgenic technology applicable to iPS cell production

Concludes Partnership Agreement for Contract Development and Manufacturing of Regenerative Medicine Products

Designation recognizes products that bring improvements to the health care industry

Company accelerates investment of approximately 3.2 billion yen for boosting CDMO capacity

November 6, 2017

BOTHELL, WA., October 27, 2017 (Booth #2307) –  FUJIFILM SonoSite, Inc., specialists in developing cutting-edge ultrasound solutions and providing world-leading education to enable point-of-care visuali

BOTHELL, WA., October 27, 2017 (Booth #405) –  FUJIFILM SonoSite, Inc., specialists in developing cutting-edge ultrasound solutions and providing world-leading education to enable point-of-care visualiz

Wayne, N.J.

Wayne, NJ, October 12, 2017 –  FUJIFILM Medical Systems U.S.A. Inc.,- Endoscopy today introduced ELUXEO™, a next-generation endoscopic video imaging system to its portfolio.

Wayne, N.J., October 12, 2017 (Booth #1201) – FUJIFILM Medical Systems U.S.A., Inc – Endoscopy will debut its new innovative video endoscopy system, ELUXEO™, at the Annual Scientific Meeting of the World Congress of Gastroenterology (WCOG) at the American College of Gastroenterology (ACG) on October 13-17, 2017 at the Orange County Convention

Stamford, CT, October 6, 2017— The Health Management Academy (The Academy), a network comprised entirely of executive members from the country's largest integrated health systems, recently featured two FUJIFILM Medical System’s U.S.A., Inc.

Madison, Wisconsin, September 20, 2017— Cellular Dynamics International (CDI), a FUJIFILM company, the leading developer and manufacturer of differentiated cells derived from human induced pluripotent stem cells (iPSCs), and Nanion Technologies GmbH (Nanion

Stamford, CT, September 18, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging solutions with a comprehensive portfolio of digital radiography (DR) and mammography solutions, today a

MADISON, WIS., September 13, 2017 – Cellular Dynamics International (CDI), a FUJIFILM company, today announced that it will host the iForum^SM 2017 meetings at The Buck Institute (Novato, CA) on September 14, 2017, Ha

Teesside, U.K., September 12, 2017 – FUJIFILM Diosynth Biotechnologies, a leading Contract Development and Manufacturing Organization (CDMO) with experience focused on the development and manufacture of recombinant biopharmaceuticals and advanced therapies, has announced its opening of the 10,000 square foot,  state-of-the-art cell culture Process Development Laboratories in Wilton Centre, Teesside.

Stamford, CT, September 6, 2017–FUJIFILM Medical Systems U.S.A., Inc., a leading provider of medical informatics solutions, introduces support for DICO

Clinical Development of Liposome Drug for Improvement of Pharmacological Efficacy through Selective Delivery of Anti-Cancer Agent to Tumors

Company’s solutions to play key role in MHS Genesis project

Stamford, CT, August 21, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of Enterprise Imaging and medical informatics solutions, today announced it achieved a business milestone as the Enterprise Imag

August 8, 2017

FUJIFILM Corporation (President: Kenji Sukeno) announced the commencement of a Phase I clinical trial of its anti-cancer drug FF-10101 in the Unites States in patients with relapsed or refractory acute myeloid leukemia (AML).

Stamford, CT, August 3, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of medical informatics and diagnostic imaging products, announced the release of its Synapse PACS version 5 in the United States. Featuring the latest server-side rendering architecture, Synapse 5 is one component of Fujifilm’s comprehensive enterprise imaging portfolio which includes Synapse VNA, Enterprise Viewer, Cardiovascular, 3D, RIS and cloud services.

Stamford, CT, August 3, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of medical informatics and diagnostic imaging products, announced the release of its Synapse PACS version 5 in the United States. Featuring the latest server-side rendering architecture, Synapse 5 is one component of Fujifilm’s comprehensive enterprise imaging portfolio which includes Synapse VNA, Enterprise Viewer, Cardiovascular, 3D, RIS and cloud services.

Stamford, CT, July 31, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, today announced that The Mammography Center of Monterey, an ACR-accredited breast imaging center based in Monterey, CA, has installed Fujifilm’s ASPIRE Cristalle FFDM system with Digital Breast Tomosynthesis (DBT). The innovative 3D breast imaging technology has been in use at the center since April.

Wayne, N.J., July 31, 2017 – FUJIFILM Medical Systems U.S.A., Inc. today announced the launch of two new additions to its advanced endoscopic platform including ClutchCutter and FlushKnife devices. Designed for use with compatible endoscopes, these devices aid clinicians in performing effective endoscopic submucosal dissection (ESD) interventions within the digestive tract.

Healthcare business expanded from medical imaging to include biopharmaceuticals and regenerative medicine.

BEND, OR (July 12, 2017) — The Center Orthopedic & Neurosurgical Care & Research recently purchased new digital x-ray equipment that allows lower radiation and simplified image acquisition. They are the first organization in the Pacific Northwest to install Fujifilm’s FDR D-EVO GL for long length imaging. At 49” tall, this equipment captures an entire long length image in a single exposure instead of multiple images and exposures that would be stitched together with software.

Stamford, CT, June 28, 2017 (Booth #221) – FUJIFILM Medical Systems U.S.A., Inc., will present its comprehensive portfolio of digital radiography and mammography solutions designed to optimize workflow and increase the safety and satisfaction of patients at the American Healthcare Radiology Administrators (AHRA) 2017 Annual Meeting. The event, which is a premier educational event for radiology administration, will occur on July 9-12, 2017 at the Anaheim Convention Center in Anaheim, California.

Billingham, United Kingdom,  June 20, 2017 ‒ FUJIFILM Diosynth Biotechnologies, a leading global biologics Contract Development and Manufacturing Organization (CDMO), has announced the successful completion of its 100th program using its pAVEway™ Advanced Protein Expression system which was introduced to the market during the BIO 2007 convention in Boston, Massachusetts.

Stamford, CT, June 19, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, today announced that its Synapse PACS line has been granted Authority to Operate (ATO) on networks in the U.S. Department of Defense (DoD), making Fujifilm the first vendor with a networked medical system to attain a Risk Management Framework (RFM)-based ATO.

Wayne, N.J.,  May 10, 2017  (Booth #143)– The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. will display its latest imaging product  innovations in pulmonology at the annual meeting of the American Thoracic Society (ATS) on May 21 – 23, 2017 in Washington, D.C.

MADISON, WIS, May 8, 2017 – Opsis Therapeutics ('Opsis'), a company developing treatments for retinal diseases, today announced the formation of its scientific advisory board (SAB). Approved by the executive leadership team, the SAB is established to advise on the development and advancement to the clinic of the Opsis pipeline of first-in-class retinal cell therapies.

Wayne, N.J., May 2, 2017 (Booth #2232)– The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. will showcase its latest innovations in endoscopic imaging technologies and solutions at Digestive Disease Week (DDW). The conference which takes place May 7-9, 2017 in Chicago, IL is the largest gathering of physicians, researchers and academics in the fields of gastroenterology, endoscopy and gastrointestinal surgery.

Wayne, N.J., May 2, 2017 (Booth #329)– The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. will showcase its latest innovations in endoscopic imaging technologies and solutions at the Society of Gastroenterology Nurses and Associates (SGNA) 44th Annual Course. The annual gathering, which attracts nearly 2,000 professionals in the gastroenterology field, will occur May 7-9, 2017 in New Orleans, Louisiana.

Madison, Wisconsin, April 19, 2017— Cellular Dynamics International (CDI), a FUJIFILM company and a leading developer and manufacturer of induced pluripotent stem cells (iPS), today announced it has signed a collaboration agreement with the Harvard Stem Cell Institute (HSCI), a novel network of stem cell scientists that extends from the University to its affiliated hospitals and the biomedical industry.

Stamford, CT, February 1, 2017 (Booth #551) – FUJIFILM Medical Systems U.S.A., Inc., and FUJIFILM SonoSite, Inc. will present its comprehensive Synapse Enterprise Imaging product portfolio and its SonoSite iViz solution which integrates ultrasound with medical IT at the Healthcare Information and Management Systems Society (HIMSS) conference and exhibition held February 19-23, 2017 at Orange County Convention Center in Orlando, Florida.

Stamford, CT, January 23, 2017 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, today announced that its Digital Breast Tomosynthesis (DBT), as an optional software upgrade for its ASPIRE Cristalle digital mammography system, has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA). The optional DBT upgrade for the ASPIRE Cristalle system is now available in the United States.

Stamford, CT, January 18, 2017 – FUJIFILM Medical Systems U.S.A., Inc. has now formed a strategic alliance with Renovo Solutions to offer Technology Management Solutions which consist of multi-vendor service (MVS) options for the maintenance and management of medical imaging and biomedical equipment. The new alliance is the result of growing demand from valued Fujifilm customers seeking to gain the benefits of a single supplier MVS relationship.

Wayne, N.J., January 12, 2017 (Booth #953) – The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc., will feature its latest portfolio of endoscopic imaging products at the 53rd  Society of Thoracic Surgeons (STS) Annual Meeting, held from January 21 to January 25 in Houston, Texas.

Toronto, Canada, January 12, 2017  – FUJIFILM VisualSonics Inc., a world leader in high-frequency ultrasound imaging systems and subsidiary of FUJIFILM SonoSite, Inc., today announced clearance from Health Canada for its Vevo® MD, the world’s first Ultra High-Frequency (UHF) clinical ultrasound system. The Vevo MD uniquely operates at much higher frequencies than any conventional ultrasound system currently available.

Stamford, CT, November 22, 2016 (Booth #6713, North Building, Hall B) – The TeraMedica Division of FUJIFILM Medical Systems U.S.A., Inc., a leading provider of medical informatics solutions, announced the release of Synapse VNA version 6.2, the next generation of its enterprise-wide medical information and image management solution at the Radiological Society of North America 2016 conference and exhibition. RSNA 2016 is held November 27 – December 2, 2016 at McCormick Center in Chicago, Illinois.  

Stamford, CT, November 22, 2016 (Booth #6713, North Building, Hall B) – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, will showcase its evolving Enterprise Imaging portfolio of Synapse integrated solutions and spotlight enhanced features and next generation upgrades at the Radiological Society of North America 2016 conference and exhibition held November 27 – December 2, 2016 at McCormick Center in Chicago, Illinois.  

New FDR AQRO1 compact mobile DR debuts; FDR Go offers updated features.

Stamford, CT, November 22, 2016 (Booth #6713, North Building, Hall B) –FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, will present the next generation of its cutting edge image processing technology, Dynamic Visualization II at the annual meeting of the Radiological Society of North America (RSNA), from November 27 – December 2, 2016 at McCormick Center in Chicago, Illinois.  

Stamford, CT, November 22, 2016 (Booth #6713, North Building, Hall B) –FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, will demonstrate the FDR D-EVO  GL detector at the 2016 annual meeting of the Radiological Society of North America (RSNA), held November 27-December 2 at McCormick Place in Chicago, Illinois.

Company sponsors two RSNA educational sessions; hosts In-Booth Healthcare Theater; showcases comprehensive product portfolio

Stamford, CT, November 1, 2016 – The TeraMedica Division of FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, today announced an important business milestone in serving global healthcare providers. The company’s Synapse VNA, an enterprise-wide medical information and image management solution, now manages nearly 10 billion objects – data and images – via 350 installations serving more than 1000 facilities worldwide.

Billingham, United Kingdom, RTP, North Carolina and College Station, Texas, U.S.A., March 1 2017‒ FUJIFILM Diosynth Biotechnologies, a leading global biologics Contract Development and Manufacturing Organization (CDMO), has announced the expansion of its Monoclonal Antibody development and manufacturing services with the introduction of its Saturn mAb Platform™.